Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Hanan Muzeyin Kedir, Eskinder Ayalew Sisay & Alfoalem Araba Abiye. (2021) Enteric-Coated Aspirin and the Risk of Gastrointestinal Side Effects: A Systematic Review. International Journal of General Medicine 14, pages 4757-4763.
Read now
Read now
Michael E. Plazak, Mallory T. Mouradjian, Kristin Watson, Brent N. Reed, Zachary R. Noel, Sandeep Devabhakthuni & Stormi E. Gale. (2019) An aspirin a day? Clinical utility of aspirin therapy for the primary prevention of cardiovascular disease. Expert Review of Cardiovascular Therapy 17:8, pages 561-573.
Read now
Read now
Byron Cryer & Kenneth W Mahaffey. (2014) Gastrointestinal ulcers, role of aspirin, and clinical outcomes: pathobiology, diagnosis, and treatment. Journal of Multidisciplinary Healthcare 7, pages 137-146.
Read now
Read now
Danielle Duffy, Bridget Rooney, Suzanne Adams & David J Whellan. (2014) PA32540 for the secondary prevention of cardiovascular disease in patients at risk for aspirin-associated gastric ulcers. Expert Review of Cardiovascular Therapy 12:11, pages 1251-1260.
Read now
Read now
Bianca Rocca, Alfredo Dragani & Francesca Pagliaccia. (2013) Identifying determinants of variability to tailor aspirin therapy. Expert Review of Cardiovascular Therapy 11:3, pages 365-379.
Read now
Read now
Peter LM Jansen. (2011) This month in Scandinavian Journal of Gastroenterology. Scandinavian Journal of Gastroenterology 46:7-8, pages 771-772.
Read now
Read now
Articles from other publishers (16)
S. R. Gilyarevskiy, M. V. Golshmid, N. G. Bendeliani & I. M. Kuzmina. (2022) Current approaches to the selection of acetylsalicylic acid dosage forms in cardiology. Aterotromboz = Atherothrombosis 12:1, pages 8-18.
Crossref
Crossref
Dominick J. Angiolillo, Jayne Prats, Efthymios N. Deliargyris, David J Schneider, James Scheiman, Carey Kimmelstiel, Ph. Gabriel Steg, Mark Alberts, Todd Rosengart, Roxana Mehran & Deepak L. Bhatt. (2022) Pharmacokinetic and Pharmacodynamic Profile of a Novel Phospholipid Aspirin Formulation. Clinical Pharmacokinetics 61:4, pages 465-479.
Crossref
Crossref
A. V. Sidorov. (2021) Antithrombotic effect of different acetylsalicylic acid drug formulations: is there a difference?. Russian Journal of Cardiology 26:10, pages 4734.
Crossref
Crossref
Mohammad Reza Mohebbian, Md. Hanif Ali Sohag, Seyed Shahim Vedaei & Khan A. Wahid. (2021) Automated Detection of Bleeding in Capsule Endoscopy Using On-Chip Multispectral Imaging Sensors. IEEE Sensors Journal 21:13, pages 14121-14130.
Crossref
Crossref
Zhuoya Li, Zheng Wang, Baile Shen, Chen Chen, Xiaoyun Ding & Haojun Song. (2020) Effects of aspirin on the gastrointestinal tract: Pros vs. cons (Review). Oncology Letters 20:3, pages 2567-2578.
Crossref
Crossref
O M Drapkina & O N Korneeva. (2016) Small bowel injuries due to nonsteroidal anti-inflammatory drugs and antiplatelet therapy. Approaches to prevention and treatment. Terapevticheskii arkhiv 88:12, pages 133-139.
Crossref
Crossref
Luis A. García Rodríguez, Mar Martín-Pérez, Charles H. Hennekens, Peter M. Rothwell & Angel Lanas. (2016) Bleeding Risk with Long-Term Low-Dose Aspirin: A Systematic Review of Observational Studies. PLOS ONE 11:8, pages e0160046.
Crossref
Crossref
Jay L. Goldstein, David J. Whellan, James M. Scheiman, Byron L. Cryer, Glenn M. Eisen, Angel Lanas & John G. Fort. (2016)
Long‐Term Safety of a Coordinated Delivery Tablet of Enteric‐Coated Aspirin 325 mg and Immediate‐Release Omeprazole 40 mg for Secondary Cardiovascular Disease Prevention in Patients at
GI
Risk
. Cardiovascular Therapeutics 34:2, pages 59-66.
Crossref
Crossref
Carmelo Scarpignato, Angel Lanas, Corrado Blandizzi, Willem F Lems, Matthias Hermann & Richard H Hunt. (2015) Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis – an expert consensus addressing benefits as well as gastrointestinal and cardiovascular risks. BMC Medicine 13:1.
Crossref
Crossref
Hiroki Endo, Eiji Sakai, Takayuki Kato, Shotaro Umezawa, Takuma Higurashi, Hidenori Ohkubo & Atsushi Nakajima. (2014) Small bowel injury in low-dose aspirin users. Journal of Gastroenterology 50:4, pages 378-386.
Crossref
Crossref
Koto Ishida & Steven R. Messé. (2014) Antiplatelet Strategies for Secondary Prevention of Stroke and TIA. Current Atherosclerosis Reports 16:11.
Crossref
Crossref
David J. Whellan, Jay L. Goldstein, Byron L. Cryer, Glenn M. Eisen, Angel Lanas, Alan B. Miller, James M. Scheiman, John G. Fort, Ying Zhang & Christopher O’Connor. (2014) PA32540 (a coordinated-delivery tablet of enteric-coated aspirin 325 mg and immediate-release omeprazole 40 mg) versus enteric-coated aspirin 325 mg alone in subjects at risk for aspirin-associated gastric ulcers: Results of two 6-month, phase 3 studies. American Heart Journal 168:4, pages 495-502.e4.
Crossref
Crossref
Akiko Shiotani, Takahisa Murao, Yoshihiko Fujita, Yoshinori Fujimura, Takashi Sakakibara, Kazuto Nishio & Ken Haruma. (2013) Novel Single Nucleotide Polymorphism Markers for Low Dose Aspirin-Associated Small Bowel Bleeding. PLoS ONE 8:12, pages e84244.
Crossref
Crossref
Mitsutaka Takada. (2013) Study on Risk of Gastrointestinal Complications in Low-dose Aspirin Therapy Using the National Receipt Database. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) 39:8, pages 471-481.
Crossref
Crossref
Hiroki Endo, Eiji Sakai, Takuma Higurashi, Eiji Yamada, Hidenori Ohkubo, Hiroshi Iida, Tomoko Koide, Masato Yoneda, Yasunobu Abe, Masahiko Inamori, Kunihiro Hosono, Hirokazu Takahashi, Kensuke Kubota & Atsushi Nakajima. (2012) Differences in the severity of small bowel mucosal injury based on the type of aspirin as evaluated by capsule endoscopy. Digestive and Liver Disease 44:10, pages 833-838.
Crossref
Crossref
Bianca Rocca & Giovanna Petrucci. (2012) Variability in the Responsiveness to Low-Dose Aspirin: Pharmacological and Disease-Related Mechanisms. Thrombosis 2012, pages 1-11.
Crossref
Crossref